Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Oct;39(4):528–531. doi: 10.1136/gut.39.4.528

5-hydroxytryptamine release into human jejunum by cholera toxin.

C P Bearcroft 1, D Perrett 1, M J Farthing 1
PMCID: PMC1383264  PMID: 8944560

Abstract

BACKGROUND: Cholera toxin produces intestinal secretion by activation of the adenylate cyclase complex. However animal studies have shown 5-hydroxytryptamine may be released after exposure to cholera toxin, and thereby contribute to the secretory state. AIM: To determine whether cholera toxin releases 5-hydroxytryptamine in human jejunum. SUBJECTS: Seven male subjects were given a subclinical dose of cholera toxin in a paired, controlled, randomised, double blind study. METHODS: A closed 10 cm segment of upper jejunum was exposed to 15 micrograms of cholera toxin for two hours prior to closed segment perfusion with plasma electrolyte solution containing a non-absorbable volume marker, [14C]-polyethylene glycol. 5-Hydroxytryptamine in jejunal effluent and 5-hydroxyindoleacetic acid in urine (up to seven hours after cholera toxin) were measured by high performance liquid chromatography with fluorimetric detection. RESULTS: In contrast with controls, all subjects secreted fluid in response to cholera toxin, median-2.1 ml/cm/h (interquartile range-4.1 to -0.1). During seven hours following cholera toxin, 5-hydroxytryptamine was secreted into the lumen (range 31 to 395 nmol/l) but not in control experiments. After exposure to cholera toxin median urinary 5-hydroxyindoleacetic acid was 5.7 (4.1 to 6.3), which was similar to controls 4.9 (4.1 to 6.3), which was similar to controls 4.9 (4.1 to 6.2). CONCLUSION: Thus, cholera toxin induced a secretory state and promoted the release of 5-hydroxytryptamine into the intestinal lumen, but quantitative changes in urinary 5-hydroxyindoleacetic acid were not detectable. As an intestinal secretagogue, these findings suggest that 5-hydroxytryptamine may play a part in mediating cholera toxin induced secretion in humans.

Full text

PDF
528

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bearcroft C. P., Farthing M. J., Perrett D. Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and tryptophan in plasma and urine by HPLC with fluorimetric detection. Biomed Chromatogr. 1995 Jan-Feb;9(1):23–27. doi: 10.1002/bmc.1130090105. [DOI] [PubMed] [Google Scholar]
  2. Bennett A. Cholera and prostaglandins. Nature. 1971 Jun 25;231(5304):536–536. doi: 10.1038/231536a0. [DOI] [PubMed] [Google Scholar]
  3. Beubler E., Horina G. 5-HT2 and 5-HT3 receptor subtypes mediate cholera toxin-induced intestinal fluid secretion in the rat. Gastroenterology. 1990 Jul;99(1):83–89. doi: 10.1016/0016-5085(90)91233-v. [DOI] [PubMed] [Google Scholar]
  4. Beubler E., Kollar G., Saria A., Bukhave K., Rask-Madsen J. Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroenterology. 1989 Feb;96(2 Pt 1):368–376. doi: 10.1016/0016-5085(89)91560-6. [DOI] [PubMed] [Google Scholar]
  5. Carpenter C. C. The pathophysiology of secretory diarrheas. Med Clin North Am. 1982 May;66(3):597–610. doi: 10.1016/s0025-7125(16)31409-2. [DOI] [PubMed] [Google Scholar]
  6. Cassuto J., Jodal M., Tuttle R., Lundgren O. 5-hydroxytryptamine and cholera secretion. Physiological and pharmacological studies in cats and rats. Scand J Gastroenterol. 1982 Aug;17(5):695–703. doi: 10.3109/00365528209181081. [DOI] [PubMed] [Google Scholar]
  7. Hicks T., Turnberg L. A. The influence of secretin on ion transport in the human jejunum. Gut. 1973 Jun;14(6):485–490. doi: 10.1136/gut.14.6.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hunt J. B., Elliott E. J., Farthing M. J. Efficacy of a standard United Kingdom oral rehydration solution (ORS) and a hypotonic ORS assessed by human intestinal perfusion. Aliment Pharmacol Ther. 1989 Dec;3(6):565–571. doi: 10.1111/j.1365-2036.1989.tb00249.x. [DOI] [PubMed] [Google Scholar]
  9. Hunt J. B., Thillainayagam A. V., Carnaby S., Fairclough P. D., Clark M. L., Farthing M. J. A new model of human secretory diarrhoea using cholera toxin. Aliment Pharmacol Ther. 1992 Oct;6(5):619–627. doi: 10.1111/j.1365-2036.1992.tb00576.x. [DOI] [PubMed] [Google Scholar]
  10. Mourad F. H., O'Donnell L. J., Dias J. A., Ogutu E., Andre E. A., Turvill J. L., Farthing M. J. Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. Gut. 1995 Sep;37(3):340–345. doi: 10.1136/gut.37.3.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nilsson O., Cassuto J., Larsson P. A., Jodal M., Lidberg P., Ahlman H., Dahlström A., Lundgren O. 5-Hydroxytryptamine and cholera secretion: a histochemical and physiological study in cats. Gut. 1983 Jun;24(6):542–548. doi: 10.1136/gut.24.6.542. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES